Derniers essais

EudraCT Number: 2004-004148-34

Sponsor Protocol Number: B9E-XM-O435

Start Date: 2005-02-25

Sponsor Name: Dr. José Ignacio Chacón López-Muñiz

Full Title: ENSAYO EN FASE I/II DE LA COMBINACIÓN DE GEMCITABINA EN INFUSIÓN PROLONGADA Y PACLITAXEL ADMINISTRADOS DE FORMA QUINCENAL EN EL TRATAMIENTO DE PRIMERA LÍNEA DE PACIENTES CON CÁNCER DE MAMA AVANZADO

Medical condition: Cancer de mama avanzado

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Female

Trial protocol: ES (Ongoing)

Trial results: (No results available)

EudraCT Number: 2004-001060-50

Sponsor Protocol Number: CSPP100A2303

Start Date: 2005-02-25

Sponsor Name: Novartis Pharma Services AG

Full Title: An eight-week, randomized, double-blind, multi-center, active-controlled, parallel group study to evaluate the safety and efficacy of an aliskiren based regimen compared to a lisinopril based regim...

Medical condition: Hypertension

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: HU (Completed) ES (Completed)

Trial results: View results

EudraCT Number: 2005-000693-45

Sponsor Protocol Number: RCOMP05

Start Date: 2005-02-24

Sponsor Name: G.I.S.L. - GRUPPO ITALIANO STUDIO LINFOMI

Full Title: A phase II study for the treatment of patients with splenic marginal lymphoma with the combination of Cyclophosfamide, Vincristine, Liposomal Doxorubicin, Predinisone and Rituximab

Medical condition: Treatment of patients with newly diagnosed splenic marginal non Hodgkin lymphoma

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10062113	Splenic marginal zone lymphoma	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: (No results available)

EudraCT Number: 2004-005101-29

Sponsor Protocol Number: KCH-MDS-04-1.0

Start Date: 2005-02-24

Sponsor Name: King's College Hospital NHS Foundation Trust [...] 1. King's College Hospital NHS Foundation Trust 2. King's College London

Full Title: THE EFFICACY AND SAFETY OF LENALIDOMIDE (Revlimid®) MONOTHERAPY IN RED BLOOD CELL TRANSFUSION DEPENDENT SUBJECTS WITH MYELODYSPLASTIC SYNDROME ASSOCIATED WITH A DEL (5q) CYTOGENETIC ABNORMALITY

Medical condition: Myelodysplastic Syndrome (MDS) associated with a Del (5q) cytogenetic abnormality

Disease:	Version	SOC Term	Classification Code	Term	Level
	16.0	100000004864	10067097	5q minus MDS	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed)

Trial results: View results

EudraCT Number: 2004-003866-13

Sponsor Protocol Number: CCR102881

Start Date: 2005-02-24

Sponsor Name: GlaxoSmithKline Research & Development Limited

Full Title: A phase IIb, 96 week, randomised, partially,double-blinded,multicentre,parallel group, repeat dose study to evaluate the safety, tolerability, pharmacokinetics and antiviral effect of GW873140 in c...

Medical condition: Treatment of HIV-1 infections

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adolescents, Adults

Gender: Male, Female

Trial protocol: DE (Completed) IT (Prematurely Ended) GB (Prematurely Ended) BE (Completed) ES (Completed)

Trial results: View results

EudraCT Number: 2004-004160-67

Sponsor Protocol Number: Protocol F1J-MC-SBCT (a)

Start Date: 2005-02-24

Sponsor Name: Eli Lilly and Company Limited

Full Title: Effect of Duloxetine on Valsalva Leak Point Pressure and Quantitative Rhabdosphincter Electromyography Measures in Women with Stress Urinary Incontinence

Medical condition: stress urinary incontinence

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Female

Trial protocol: GB (Completed) DK (Completed)

Trial results: View results

EudraCT Number: 2004-005074-24

Sponsor Protocol Number: Feb-02

Start Date: 2005-02-23

Sponsor Name: Febena Pharma GmbH

Full Title: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF AN OINTMENT FORMULATION CONTAINING DEXAMETHASONE IN PATIENTS WITH RHINOSINUSITIS A CLINICAL PHASE IV ...

Medical condition: Patients with allergy-induced, non-infectious diseases of the nasal mucosa (e. g. hay fever) and the sinuses.

Disease:	Version	SOC Term	Classification Code	Term	Level
	12.1		10052106	Rhinosinusitis	LLT

Population Age: Adults

Gender: Male, Female

Trial protocol: DE (Ongoing)

Trial results: (No results available)

EudraCT Number: 2004-002020-17

Sponsor Protocol Number: 10908458

Start Date: 2005-02-23

Sponsor Name: Catalan Society of Family Medicine, represented by Dr Mariano de la Figuera Von Wichman and Gabriel

Full Title: ESTRATEGIAS PARA EL TRATAMIENTO DE LA HIPERTENSIÓN ARTERIAL. EVALUACIÓN DE UNA TERAPIA COMBINADA A DOSIS FIJAS (LOSARTÁN/HIDROCLOROTIAZIDA) vs MONOTERAPIA (ESTRATAAR). (STRATEGIES FOR THE TREATMENT...

Medical condition: Stage II arterial Hypertension

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: ES (Ongoing)

Trial results: (No results available)

EudraCT Number: 2004-004899-36

Sponsor Protocol Number: Mekos 05 P379/1

Start Date: 2005-02-23

Sponsor Name: Mekos Laboratories

Full Title: Clinical evaluation of the 3 allergens: Methyldibromoglutharonitrile, Parthenolide and Goldsodiumthiosulphate for "TRUE Test Panel 3" - a phase II, dose-response study.

Medical condition: Diagnosis of Allergic Contact Dermatitis.

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: SE (Ongoing) DK (Completed)

Trial results: (No results available)

EudraCT Number: 2004-000903-17

Sponsor Protocol Number: CN138-166

Start Date: 2005-02-23

Sponsor Name: Bristol-Myers Squibb International Corporation

Full Title: A Prospective, Multicenter, Open-Label Study to Evaluate the Effectiveness and the Effect on Cognitive Functioning of a Treatment with Aripiprazole in a Broad Range of Schizophrenic Patients

Medical condition: Schizophrenia

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: BE (Completed)

Trial results: View results

Derniers essais

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue